Willow Biosciences Inc WLLW

TOR: WLLW | ISIN: CA97111B4047   10/05/2024
0,090 CAD (0,00%)
(0,00%)   10/05/2024
Grafiek Willow Biosciences Inc Grafiek Willow Biosciences Inc

Willow Biosciences Inc in het nieuws

29 maart 2024 · Willow Biosciences Reports Fourth Quarter And Fiscal Year 2023 Financials And Operations And Filing Of Its 2023 Aif · Persbericht

1 maart 2024 · Willow Biosciences Announces Second Strategic Investment From Kalsec · Persbericht

21 februari 2024 · Willow Biosciences Announces Strategic Investment From Kalsec To Develop Innovative Natural Food Ingredients · Persbericht

31 januari 2024 · Willow Announces Collaboration With Global Ingredient Manufacturer To Develop A More Cost-Effective, Sustainable Process For A Large Volume Active Pharmaceutical Ingredient · Persbericht

16 januari 2024 · Willow Announces Collaboration With Enterin To Develop Sustainable Intermediates And Active Pharmaceutical Ingredients · Persbericht

10 januari 2024 · Willow Plans For Significant Growth In 2024 On The Back Of A Successful 2023 · Persbericht

7 december 2023 · Willow And Leading Innovative Biopharmaceutical Company Advance Development Program To Manufacture Sustainable Intermediates And Active Pharmaceutical Ingredients · Persbericht

11 oktober 2023 · Willow Biosciences Announces Completion Of Previously Announced Convertible Debenture Financing · Persbericht

3 oktober 2023 · Willow And Suanfarma Announce Collaboration On Development Of Large Volume Anti-Infective Api Through Precision Fermentation · Persbericht

3 oktober 2023 · Willow Et Suanfarma Annoncent Leur Collaboration Pour Le Développement D'un Grand Volume D'api Anti-Infectieux Par Le Biais De La Fermentation De Précision · Persbericht

Profiel Willow Biosciences Inc

Commerciële diensten
Diverse commerciële diensten
Mijnbouw, steenhouwerij en olie- en gaswinning
Winning van edelstenen en delfstoffen

CEO: Trevor Peters

Aandelen Willow Biosciences Inc

Beurswaarde: 11,45 miljoen CAD

Effecten: 127,22 miljoen

Mijn selecties